Cochrane's Strategy to 2020 aims to put Cochrane evidence at the heart of health decision-making all over the world. It defines how we intend to accomplish this and provides a framework for Cochrane’s future decision-making, helping us respond to the strategic opportunities and challenges that we face in the next decade and beyond. It is the result of a collaborative process undertaken by our global network of contributors; and represents the collective vision of the organization to 2020 that relies on those contributors to ensure its success.
Cochrane's 2016 Annual General Meeting, held in Seoul during our annual Colloquium, included a Special Session where the Cochrane Community had the opportunity to share their stories of responding to the challenges of Strategy to 2020. As well as live presentations from a selection of Cochrane Groups from around the world, the session included this video highlighting just a few stories among many of what Strategy to 2020 means to Cochrane Groups and their work within local contexts.
